569 related articles for article (PubMed ID: 347855)
1. Serum lipids and lipoproteins during treatment with oral contraceptives containing natural and synthetic oestrogens. A controlled double-blind investigation.
Bostofte E; Hemmingsen L; Møller KJ; Serup J; Weber T
Acta Endocrinol (Copenh); 1978 Apr; 87(4):855-64. PubMed ID: 347855
[TBL] [Abstract][Full Text] [Related]
2. Comparative studies of the ethynyl estrogens used in oral contraceptives. VII. Effects with and without progestational agents on ultracentrifugally fractionated plasma lipoproteins in humans, baboons, and beagles.
Goldzieher JW; Chenault CB; de la Peña A; Dozier TS; Kraemer DC
Fertil Steril; 1978 Nov; 30(5):522-33. PubMed ID: 214353
[TBL] [Abstract][Full Text] [Related]
3. Effect of estrogen/progestin potency on lipid/lipoprotein cholesterol.
Wahl P; Walden C; Knopp R; Hoover J; Wallace R; Heiss G; Rifkind B
N Engl J Med; 1983 Apr; 308(15):862-7. PubMed ID: 6572785
[TBL] [Abstract][Full Text] [Related]
4. A randomized, double-blind study of two combined oral contraceptives containing the same progestogen, but different estrogens. World Health Organization Task Force on Oral Contraception.
Contraception; 1980 May; 21(5):445-59. PubMed ID: 7428356
[TBL] [Abstract][Full Text] [Related]
5. A two-year clinical study of the effects of two triphasic oral contraceptives on plasma lipids.
Kakis G; Powell M; Marshall A; Woutersz TB; Steiner G
Int J Fertil Menopausal Stud; 1994; 39(5):283-91. PubMed ID: 7820162
[TBL] [Abstract][Full Text] [Related]
6. Control of fertility with oral medication.
Diddle AW; Watts GF; Gardner WH; Williamson PJ
West J Surg Obstet Gynecol; 1964; 72():222-9. PubMed ID: 12305556
[TBL] [Abstract][Full Text] [Related]
7. Oestriol deficiency, a possible factor in the aetiology of thrombo-embolism in pill users.
Zaki K; Sami G; Nour H
Egypt Popul Fam Plann Rev; 1972 Jun; 5(1):19-24. PubMed ID: 12256026
[TBL] [Abstract][Full Text] [Related]
8. Effectivity and acceptability of oral contraceptives containing natural and artificial estrogens in combination with a gestagen. A controlled double-blind investigation.
Serup J; Bostofte E; Larsen S; Westergaard J
Acta Obstet Gynecol Scand; 1981; 60(2):203-6. PubMed ID: 7018165
[TBL] [Abstract][Full Text] [Related]
9. Relationships between blood pressure, oral contraceptive use and metabolic risk markers for cardiovascular disease.
Godsland IF; Crook D; Devenport M; Wynn V
Contraception; 1995 Sep; 52(3):143-9. PubMed ID: 7587185
[TBL] [Abstract][Full Text] [Related]
10. Hirsutism: metabolic effects of two commonly used oral contraceptives and spironolactone.
Wild RA; Demers LM; Applebaum-Bowden D; Lenker R
Contraception; 1991 Aug; 44(2):113-24. PubMed ID: 1893706
[TBL] [Abstract][Full Text] [Related]
11. Progestins and oral contraceptive-induced lipoprotein changes: a prospective study.
Lipson A; Stoy DB; LaRosa JC; Muesing RA; Cleary PA; Miller VT; Gilbert PR; Stadel B
Contraception; 1986 Aug; 34(2):121-34. PubMed ID: 3096633
[TBL] [Abstract][Full Text] [Related]
12. Liver function tests in patients on oral progestogens.
Engineer AD; Gupta V; Tandon P
J Obstet Gynaecol India; 1968 Apr; 18(2):598-605. PubMed ID: 12331828
[TBL] [Abstract][Full Text] [Related]
13. Treatment of climacteric and postmenopausal women with 17-beta-oestradiol and norethisterone acetate.
Furuhjelm M; Carlström K
Acta Obstet Gynecol Scand; 1977; 56(4):351-61. PubMed ID: 602703
[TBL] [Abstract][Full Text] [Related]
14. Studies on the role of intestinal bacteria in metabolism of synthetic and natural steroid hormones.
Adlercreutz H; Pulkkinen MO; Hämäläinen EK; Korpela JT
J Steroid Biochem; 1984 Jan; 20(1):217-29. PubMed ID: 6231418
[TBL] [Abstract][Full Text] [Related]
15. Effect of oral contraception on water-suppressed proton NMR spectra of plasma.
Carlier PG; Vaesen F; Gilles RG; Fradin EA; Rorive GL
Magn Reson Med; 1991 Jan; 17(1):269-73. PubMed ID: 1648654
[TBL] [Abstract][Full Text] [Related]
16. Insulin sensitivity is decreased in normal women by doses of ethinyl estradiol used in oral contraceptives.
Kojima T; Lindheim SR; Duffy DM; Vijod MA; Stanczyk FZ; Lobo RA
Am J Obstet Gynecol; 1993 Dec; 169(6):1540-4. PubMed ID: 8267059
[TBL] [Abstract][Full Text] [Related]
17. Factors affecting pituitary gonadotropin function in users of oral contraceptive steroids.
Scott JA; Brenner PF; Kletzky OA; Mishell DR
Am J Obstet Gynecol; 1978 Apr; 130(7):817-21. PubMed ID: 345817
[TBL] [Abstract][Full Text] [Related]
18. Vaginal administration of a combined oral contraceptive containing norethisterone acetate.
Souka AR; Kamel M; Einen MA; Saleh F; Sallam H
Contraception; 1985 Jun; 31(6):571-81. PubMed ID: 3899504
[TBL] [Abstract][Full Text] [Related]
19. Adrenocortical function of patients using oral contraceptives.
Kauppila A; Järvinen PA; Ylöstalo P; Reinilä M
Acta Obstet Gynecol Scand; 1974; 53(2):155-9. PubMed ID: 4362662
[TBL] [Abstract][Full Text] [Related]
20. Carbohydrate metabolism in Gynanovlar 21 and Lyndiol 2.5 users.
Kamal I; Zaki K; Rashad S
Egypt Popul Fam Plann Rev; 1972 Jun; 5(1):67-77. PubMed ID: 12256028
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
